APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nucleic Acid Extraction

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nucleic Acid Extraction Market Outlook and Growth Opportunities 2026

29 December 2025205 pages

Choose your research edition.

Industry ResearchNucleic Acid Extraction Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Nucleic Acid Extraction Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Nucleic Acid Extraction Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nucleic Acid Extraction Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Nucleic Acid Extraction Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Nucleic Acid Extraction market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nucleic Acid Extraction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nucleic Acid Extraction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nucleic Acid Extraction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nucleic Acid Extraction market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nucleic Acid Extraction market include Thermo Fisher Scientific, Takara, Source BioScience, Reprocell, Promega Corporation, PerkinElmer, NTL Biotech, LGC Biosearch Technologies and LC Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nucleic Acid Extraction market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nucleic Acid Extraction and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nucleic Acid Extraction revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nucleic Acid Extraction market.

Nucleic Acid Extraction Segment by Company

Thermo Fisher Scientific

Takara

Source BioScience

Reprocell

Promega Corporation

PerkinElmer

NTL Biotech

LGC Biosearch Technologies

LC Sciences

Kaizen Bioservices

Hokkaido System Science

Genotypic Technology

Genewiz

Eurofins Genomics

DLS

Daicel Arbor Biosciences

Biofortuna

Beckman

AutoGen

Aurora Biomed

Nucleic Acid Extraction Segment by Type

DNA Extraction

RNA Extraction

Nucleic Acid Extraction Segment by Application

Medical Research

Drug Development

Others

Nucleic Acid Extraction Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nucleic Acid Extraction status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nucleic Acid Extraction key companies, revenue, market share, and recent developments.

3. To split the Nucleic Acid Extraction breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nucleic Acid Extraction market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nucleic Acid Extraction significant trends, drivers, influence factors in global and regions.

6. To analyze Nucleic Acid Extraction competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Acid Extraction market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nucleic Acid Extraction and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Acid Extraction.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nucleic Acid Extraction industry.

Chapter 3: Detailed analysis of Nucleic Acid Extraction company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nucleic Acid Extraction in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nucleic Acid Extraction in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nucleic Acid Extraction Industry Trends Table 2. Nucleic Acid Extraction Industry Drivers Table 3. Nucleic Acid Extraction Industry Opportunities and Challenges Table 4. Nucleic Acid Extraction Industry Restraints Table 5. Global Nucleic Acid Extraction Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nucleic Acid Extraction Revenue Share by Company (2021-2026) Table 7. Global Nucleic Acid Extraction Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nucleic Acid Extraction Key Company Manufacturing Base & Headquarters Table 9. Global Nucleic Acid Extraction Company, Product Type & Application Table 10. Global Nucleic Acid Extraction Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nucleic Acid Extraction by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of DNA Extraction Table 15. Significant Companies of RNA Extraction Table 16. Global Nucleic Acid Extraction Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Nucleic Acid Extraction Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Nucleic Acid Extraction Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Nucleic Acid Extraction Sales Value Share by Type (2021-2026) Table 20. Global Nucleic Acid Extraction Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Research Table 22. Significant Companies of Drug Development Table 23. Significant Companies of Others Table 24. Global Nucleic Acid Extraction Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nucleic Acid Extraction Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Nucleic Acid Extraction Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Nucleic Acid Extraction Sales Value Share by Application (2021-2026) Table 28. Global Nucleic Acid Extraction Sales Value Share by Application (2027-2032) Table 29. Global Nucleic Acid Extraction Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Nucleic Acid Extraction Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Nucleic Acid Extraction Sales Value Share by Region (2021-2026) Table 32. Global Nucleic Acid Extraction Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Nucleic Acid Extraction Sales Value Share by Region (2027-2032) Table 34. Global Nucleic Acid Extraction Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nucleic Acid Extraction Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Nucleic Acid Extraction Sales Value Market Share by Country (2021-2026) Table 37. Global Nucleic Acid Extraction Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Nucleic Acid Extraction Sales Value Market Share by Country (2027-2032) Table 39. Thermo Fisher Scientific Company Information Table 40. Thermo Fisher Scientific Business Overview Table 41. Thermo Fisher Scientific Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Thermo Fisher Scientific Nucleic Acid Extraction Product Portfolio Table 43. Thermo Fisher Scientific Recent Development Table 44. Takara Company Information Table 45. Takara Business Overview Table 46. Takara Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Takara Nucleic Acid Extraction Product Portfolio Table 48. Takara Recent Development Table 49. Source BioScience Company Information Table 50. Source BioScience Business Overview Table 51. Source BioScience Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Source BioScience Nucleic Acid Extraction Product Portfolio Table 53. Source BioScience Recent Development Table 54. Reprocell Company Information Table 55. Reprocell Business Overview Table 56. Reprocell Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Reprocell Nucleic Acid Extraction Product Portfolio Table 58. Reprocell Recent Development Table 59. Promega Corporation Company Information Table 60. Promega Corporation Business Overview Table 61. Promega Corporation Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Promega Corporation Nucleic Acid Extraction Product Portfolio Table 63. Promega Corporation Recent Development Table 64. PerkinElmer Company Information Table 65. PerkinElmer Business Overview Table 66. PerkinElmer Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. PerkinElmer Nucleic Acid Extraction Product Portfolio Table 68. PerkinElmer Recent Development Table 69. NTL Biotech Company Information Table 70. NTL Biotech Business Overview Table 71. NTL Biotech Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. NTL Biotech Nucleic Acid Extraction Product Portfolio Table 73. NTL Biotech Recent Development Table 74. LGC Biosearch Technologies Company Information Table 75. LGC Biosearch Technologies Business Overview Table 76. LGC Biosearch Technologies Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. LGC Biosearch Technologies Nucleic Acid Extraction Product Portfolio Table 78. LGC Biosearch Technologies Recent Development Table 79. LC Sciences Company Information Table 80. LC Sciences Business Overview Table 81. LC Sciences Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. LC Sciences Nucleic Acid Extraction Product Portfolio Table 83. LC Sciences Recent Development Table 84. Kaizen Bioservices Company Information Table 85. Kaizen Bioservices Business Overview Table 86. Kaizen Bioservices Nucleic Acid Extraction Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Kaizen Bioservices Nucleic Acid Extraction Product Portfolio Table 88. Kaizen Bioservices Recent Development Table 89. Hokkaido System Science Company Information Table 90. Hokkaido System Science Business Overview Table 91. Hokkaido System Science Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hokkaido System Science Nucleic Acid Extraction Product Portfolio Table 93. Hokkaido System Science Recent Development Table 94. Genotypic Technology Company Information Table 95. Genotypic Technology Business Overview Table 96. Genotypic Technology Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Genotypic Technology Nucleic Acid Extraction Product Portfolio Table 98. Genotypic Technology Recent Development Table 99. Genewiz Company Information Table 100. Genewiz Business Overview Table 101. Genewiz Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Genewiz Nucleic Acid Extraction Product Portfolio Table 103. Genewiz Recent Development Table 104. Eurofins Genomics Company Information Table 105. Eurofins Genomics Business Overview Table 106. Eurofins Genomics Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Eurofins Genomics Nucleic Acid Extraction Product Portfolio Table 108. Eurofins Genomics Recent Development Table 109. DLS Company Information Table 110. DLS Business Overview Table 111. DLS Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. DLS Nucleic Acid Extraction Product Portfolio Table 113. DLS Recent Development Table 114. Daicel Arbor Biosciences Company Information Table 115. Daicel Arbor Biosciences Business Overview Table 116. Daicel Arbor Biosciences Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Daicel Arbor Biosciences Nucleic Acid Extraction Product Portfolio Table 118. Daicel Arbor Biosciences Recent Development Table 119. Biofortuna Company Information Table 120. Biofortuna Business Overview Table 121. Biofortuna Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Biofortuna Nucleic Acid Extraction Product Portfolio Table 123. Biofortuna Recent Development Table 124. Beckman Company Information Table 125. Beckman Business Overview Table 126. Beckman Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Beckman Nucleic Acid Extraction Product Portfolio Table 128. Beckman Recent Development Table 129. AutoGen Company Information Table 130. AutoGen Business Overview Table 131. AutoGen Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. AutoGen Nucleic Acid Extraction Product Portfolio Table 133. AutoGen Recent Development Table 134. Aurora Biomed Company Information Table 135. Aurora Biomed Business Overview Table 136. Aurora Biomed Nucleic Acid Extraction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Aurora Biomed Nucleic Acid Extraction Product Portfolio Table 138. Aurora Biomed Recent Development Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Nucleic Acid Extraction Product Image Figure 2. Global Nucleic Acid Extraction Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nucleic Acid Extraction Market Size (2021-2032) & (US$ Million) Figure 4. Global Nucleic Acid Extraction Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. DNA Extraction Image Figure 8. RNA Extraction Image Figure 9. Global Nucleic Acid Extraction Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Nucleic Acid Extraction Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Nucleic Acid Extraction Sales Value Share by Type (2021-2032) Figure 12. Medical Research Image Figure 13. Drug Development Image Figure 14. Others Image Figure 15. Global Nucleic Acid Extraction Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nucleic Acid Extraction Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nucleic Acid Extraction Sales Value Share by Application (2021-2032) Figure 18. Global Nucleic Acid Extraction Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Nucleic Acid Extraction Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Nucleic Acid Extraction Sales Value (2021-2032) & (US$ Million) Figure 21. North America Nucleic Acid Extraction Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Nucleic Acid Extraction Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Nucleic Acid Extraction Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Nucleic Acid Extraction Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Nucleic Acid Extraction Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Nucleic Acid Extraction Sales Value (2021-2032) & (US$ Million) Figure 27. South America Nucleic Acid Extraction Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Nucleic Acid Extraction Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Nucleic Acid Extraction Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Nucleic Acid Extraction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Extraction
  • RNA Extraction
Applications
  • Medical Research
  • Drug Development
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Takara
  • Source BioScience
  • Reprocell
  • Promega Corporation
  • PerkinElmer
  • NTL Biotech
  • LGC Biosearch Technologies
  • LC Sciences
  • Kaizen Bioservices
  • Hokkaido System Science
  • Genotypic Technology
  • Genewiz
  • Eurofins Genomics
  • DLS
  • Daicel Arbor Biosciences
  • Biofortuna
  • Beckman
  • AutoGen
  • Aurora Biomed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nucleic Acid Extraction Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nucleic Acid Extraction Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nucleic Acid Extraction Market Dynamics
  1. 2.1 Nucleic Acid Extraction Industry Trends
  2. 2.2 Nucleic Acid Extraction Industry Drivers
  3. 2.3 Nucleic Acid Extraction Industry Opportunities and Challenges
  4. 2.4 Nucleic Acid Extraction Industry Restraints
3 Nucleic Acid Extraction Market by Company
  1. 3.1 Global Nucleic Acid Extraction Company Revenue Ranking in 2025
  2. 3.2 Global Nucleic Acid Extraction Revenue by Company (2021-2026)
  3. 3.3 Global Nucleic Acid Extraction Company Ranking (2024-2026)
  4. 3.4 Global Nucleic Acid Extraction Company Manufacturing Base and Headquarters
  5. 3.5 Global Nucleic Acid Extraction Company Product Type and Application
  6. 3.6 Global Nucleic Acid Extraction Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nucleic Acid Extraction Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nucleic Acid Extraction Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nucleic Acid Extraction Market by Type
  1. 4.1 Nucleic Acid Extraction Type Introduction
  2. 4.1.1 DNA Extraction
  3. 4.1.2 RNA Extraction
  4. 4.2 Global Nucleic Acid Extraction Sales Value by Type
  5. 4.2.1 Global Nucleic Acid Extraction Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nucleic Acid Extraction Sales Value by Type (2021-2032)
  7. 4.2.3 Global Nucleic Acid Extraction Sales Value Share by Type (2021-2032)
5 Nucleic Acid Extraction Market by Application
  1. 5.1 Nucleic Acid Extraction Application Introduction
  2. 5.1.1 Medical Research
  3. 5.1.2 Drug Development
  4. 5.1.3 Others
  5. 5.2 Global Nucleic Acid Extraction Sales Value by Application
  6. 5.2.1 Global Nucleic Acid Extraction Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nucleic Acid Extraction Sales Value by Application (2021-2032)
  8. 5.2.3 Global Nucleic Acid Extraction Sales Value Share by Application (2021-2032)
6 Nucleic Acid Extraction Regional Value Analysis
  1. 6.1 Global Nucleic Acid Extraction Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nucleic Acid Extraction Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nucleic Acid Extraction Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nucleic Acid Extraction Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nucleic Acid Extraction Sales Value (2021-2032)
  7. 6.3.2 North America Nucleic Acid Extraction Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nucleic Acid Extraction Sales Value (2021-2032)
  10. 6.4.2 Europe Nucleic Acid Extraction Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nucleic Acid Extraction Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nucleic Acid Extraction Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nucleic Acid Extraction Sales Value (2021-2032)
  16. 6.6.2 South America Nucleic Acid Extraction Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nucleic Acid Extraction Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nucleic Acid Extraction Sales Value Share by Country, 2025 VS 2032
7 Nucleic Acid Extraction Country-level Value Analysis
  1. 7.1 Global Nucleic Acid Extraction Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nucleic Acid Extraction Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nucleic Acid Extraction Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nucleic Acid Extraction Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nucleic Acid Extraction Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nucleic Acid Extraction Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nucleic Acid Extraction Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Nucleic Acid Extraction Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Takara
  8. 8.2.1 Takara Company Information
  9. 8.2.2 Takara Business Overview
  10. 8.2.3 Takara Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takara Nucleic Acid Extraction Product Portfolio
  12. 8.2.5 Takara Recent Developments
  13. 8.3 Source BioScience
  14. 8.3.1 Source BioScience Company Information
  15. 8.3.2 Source BioScience Business Overview
  16. 8.3.3 Source BioScience Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Source BioScience Nucleic Acid Extraction Product Portfolio
  18. 8.3.5 Source BioScience Recent Developments
  19. 8.4 Reprocell
  20. 8.4.1 Reprocell Company Information
  21. 8.4.2 Reprocell Business Overview
  22. 8.4.3 Reprocell Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Reprocell Nucleic Acid Extraction Product Portfolio
  24. 8.4.5 Reprocell Recent Developments
  25. 8.5 Promega Corporation
  26. 8.5.1 Promega Corporation Company Information
  27. 8.5.2 Promega Corporation Business Overview
  28. 8.5.3 Promega Corporation Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Promega Corporation Nucleic Acid Extraction Product Portfolio
  30. 8.5.5 Promega Corporation Recent Developments
  31. 8.6 PerkinElmer
  32. 8.6.1 PerkinElmer Company Information
  33. 8.6.2 PerkinElmer Business Overview
  34. 8.6.3 PerkinElmer Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PerkinElmer Nucleic Acid Extraction Product Portfolio
  36. 8.6.5 PerkinElmer Recent Developments
  37. 8.7 NTL Biotech
  38. 8.7.1 NTL Biotech Company Information
  39. 8.7.2 NTL Biotech Business Overview
  40. 8.7.3 NTL Biotech Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NTL Biotech Nucleic Acid Extraction Product Portfolio
  42. 8.7.5 NTL Biotech Recent Developments
  43. 8.8 LGC Biosearch Technologies
  44. 8.8.1 LGC Biosearch Technologies Company Information
  45. 8.8.2 LGC Biosearch Technologies Business Overview
  46. 8.8.3 LGC Biosearch Technologies Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LGC Biosearch Technologies Nucleic Acid Extraction Product Portfolio
  48. 8.8.5 LGC Biosearch Technologies Recent Developments
  49. 8.9 LC Sciences
  50. 8.9.1 LC Sciences Company Information
  51. 8.9.2 LC Sciences Business Overview
  52. 8.9.3 LC Sciences Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LC Sciences Nucleic Acid Extraction Product Portfolio
  54. 8.9.5 LC Sciences Recent Developments
  55. 8.10 Kaizen Bioservices
  56. 8.10.1 Kaizen Bioservices Company Information
  57. 8.10.2 Kaizen Bioservices Business Overview
  58. 8.10.3 Kaizen Bioservices Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kaizen Bioservices Nucleic Acid Extraction Product Portfolio
  60. 8.10.5 Kaizen Bioservices Recent Developments
  61. 8.11 Hokkaido System Science
  62. 8.11.1 Hokkaido System Science Company Information
  63. 8.11.2 Hokkaido System Science Business Overview
  64. 8.11.3 Hokkaido System Science Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hokkaido System Science Nucleic Acid Extraction Product Portfolio
  66. 8.11.5 Hokkaido System Science Recent Developments
  67. 8.12 Genotypic Technology
  68. 8.12.1 Genotypic Technology Company Information
  69. 8.12.2 Genotypic Technology Business Overview
  70. 8.12.3 Genotypic Technology Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genotypic Technology Nucleic Acid Extraction Product Portfolio
  72. 8.12.5 Genotypic Technology Recent Developments
  73. 8.13 Genewiz
  74. 8.13.1 Genewiz Company Information
  75. 8.13.2 Genewiz Business Overview
  76. 8.13.3 Genewiz Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Genewiz Nucleic Acid Extraction Product Portfolio
  78. 8.13.5 Genewiz Recent Developments
  79. 8.14 Eurofins Genomics
  80. 8.14.1 Eurofins Genomics Company Information
  81. 8.14.2 Eurofins Genomics Business Overview
  82. 8.14.3 Eurofins Genomics Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Eurofins Genomics Nucleic Acid Extraction Product Portfolio
  84. 8.14.5 Eurofins Genomics Recent Developments
  85. 8.15 DLS
  86. 8.15.1 DLS Company Information
  87. 8.15.2 DLS Business Overview
  88. 8.15.3 DLS Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  89. 8.15.4 DLS Nucleic Acid Extraction Product Portfolio
  90. 8.15.5 DLS Recent Developments
  91. 8.16 Daicel Arbor Biosciences
  92. 8.16.1 Daicel Arbor Biosciences Company Information
  93. 8.16.2 Daicel Arbor Biosciences Business Overview
  94. 8.16.3 Daicel Arbor Biosciences Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Daicel Arbor Biosciences Nucleic Acid Extraction Product Portfolio
  96. 8.16.5 Daicel Arbor Biosciences Recent Developments
  97. 8.17 Biofortuna
  98. 8.17.1 Biofortuna Company Information
  99. 8.17.2 Biofortuna Business Overview
  100. 8.17.3 Biofortuna Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biofortuna Nucleic Acid Extraction Product Portfolio
  102. 8.17.5 Biofortuna Recent Developments
  103. 8.18 Beckman
  104. 8.18.1 Beckman Company Information
  105. 8.18.2 Beckman Business Overview
  106. 8.18.3 Beckman Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Beckman Nucleic Acid Extraction Product Portfolio
  108. 8.18.5 Beckman Recent Developments
  109. 8.19 AutoGen
  110. 8.19.1 AutoGen Company Information
  111. 8.19.2 AutoGen Business Overview
  112. 8.19.3 AutoGen Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  113. 8.19.4 AutoGen Nucleic Acid Extraction Product Portfolio
  114. 8.19.5 AutoGen Recent Developments
  115. 8.20 Aurora Biomed
  116. 8.20.1 Aurora Biomed Company Information
  117. 8.20.2 Aurora Biomed Business Overview
  118. 8.20.3 Aurora Biomed Nucleic Acid Extraction Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Aurora Biomed Nucleic Acid Extraction Product Portfolio
  120. 8.20.5 Aurora Biomed Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst